These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 35968319)
1. Consensus on early detection of disease progression in patients with multiple sclerosis. Meca-Lallana JE; Casanova B; Rodríguez-Antigüedad A; Eichau S; Izquierdo G; Durán C; Río J; Hernández MÁ; Calles C; Prieto-González JM; Ara JR; Uría DF; Costa-Frossard L; García-Merino A; Oreja-Guevara C Front Neurol; 2022; 13():931014. PubMed ID: 35968319 [TBL] [Abstract][Full Text] [Related]
2. Identification and diagnosis of Secondary Progressive Multiple Sclerosis during the clinical encounter: Results from a physician survey. Alvarez E; Nair KV; Gorritz M; Bartolome L; Maloney H; Ding Y; Golan T; Wade RL; Kumar R; Su W; Shah R; Russo P Mult Scler Relat Disord; 2021 May; 50():102858. PubMed ID: 33799068 [TBL] [Abstract][Full Text] [Related]
3. A mixed methods approach towards understanding key disease characteristics associated with the progression from RRMS to SPMS: Physicians' and patients' views. Ziemssen T; Tolley C; Bennett B; Kilgariff S; Jones E; Pike J; Tomic D; Piani-Meier D; Lahoz R Mult Scler Relat Disord; 2020 Feb; 38():101861. PubMed ID: 31865132 [TBL] [Abstract][Full Text] [Related]
4. Approaches and challenges in the diagnosis and management of secondary progressive multiple sclerosis: A Central Eastern European perspective from healthcare professionals. Boyko A; Therapontos C; Horakova D; Szilasiová J; Kalniņa J; Kolontareva J; Gross-Paju K; Selmaj K; Sereike I; Milo R; Gabelić T; Rot U Mult Scler Relat Disord; 2021 May; 50():102778. PubMed ID: 33592384 [TBL] [Abstract][Full Text] [Related]
5. Results from SPECTRUM: A survey of healthcare professionals to understand current diagnosis and management practices for secondary progressive multiple sclerosis in the United Kingdom. Duddy M; Wilkinson C; Medhurst S; Rhys K Mult Scler Relat Disord; 2021 Oct; 55():103174. PubMed ID: 34399317 [TBL] [Abstract][Full Text] [Related]
6. A Physician-Completed Digital Tool for Evaluating Disease Progression (Multiple Sclerosis Progression Discussion Tool): Validation Study. Ziemssen T; Piani-Meier D; Bennett B; Johnson C; Tinsley K; Trigg A; Hach T; Dahlke F; Tomic D; Tolley C; Freedman MS J Med Internet Res; 2020 Feb; 22(2):e16932. PubMed ID: 32049062 [TBL] [Abstract][Full Text] [Related]
7. Secondary progressive multiple sclerosis: A national consensus paper on diagnostic criteria. Ciron J; Gueguen A; Al Khedr A; Bourre B; Clavelou P; Defer G; Durand-Dubief F; Labauge P; Ouallet JC; Pittion Vouyovitch S; Tourbah A; Vermersch P Rev Neurol (Paris); 2022 Dec; 178(10):1098-1104. PubMed ID: 36180289 [TBL] [Abstract][Full Text] [Related]
8. Consensus for the Early Identification of Secondary Progressive Multiple Sclerosis in Portugal: a Delphi Panel. Sá MJ; Basílio C; Capela C; Cerqueira JJ; Mendes I; Morganho A; Correia de Sá J; Salgado V; Martins Silva A; Vale J; Sousa L Acta Med Port; 2023 Mar; 36(3):167-173. PubMed ID: 36735763 [TBL] [Abstract][Full Text] [Related]
9. Application of definitions for conversion to secondary progressive MS in a Danish nationwide population. Kopp TI; Bramow S; Illes Z; Kant M; Kristensen C; Rasmussen PV; Sellebjerg F; Magyari M Mult Scler Relat Disord; 2021 Nov; 56():103319. PubMed ID: 34666241 [TBL] [Abstract][Full Text] [Related]
10. Secondary Progressive Multiple Sclerosis: New Insights. Cree BAC; Arnold DL; Chataway J; Chitnis T; Fox RJ; Pozo Ramajo A; Murphy N; Lassmann H Neurology; 2021 Aug; 97(8):378-388. PubMed ID: 34088878 [TBL] [Abstract][Full Text] [Related]